BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As the autoimmune wave breathes financial life back into the a
 llogeneic space\, and a growing number of oncology pipelines entering the
  clinic\, it is now business critical that allogeneic drug developers pro
 ve the potential of the off-the-shelf approach to enable reduced cost of 
 goods and greater access for patients.\n\nAs the must-attend meeting for 
 the allogeneic community\, the 7th Annual Allogeneic Cell Therapies Summi
 t will address the critical challenges in optimizing complex gene enginee
 ring\, ensuring safety and potency of off-the-shelf cell therapies to acc
 elerate your path to clinical and commercial success.\n\nSpanning preclin
 ical development through to manufacturing and process development\, brain
 storm with industry pioneers the best approaches for developing preclinic
 al assays\, targeting novel cell types and streamlining automated manufac
 turing processes to support scale-up for larger patient populations.\n\nC
 overing disease indications in both oncology and autoimmunity\, connect w
 ith expert speakers from Adicet Bio\, Caribou Bioscience\, IN8Bio and mor
 e\, as they share innovations in non-viral engineering and manufacturing\
 , the latest advancements in cell expansion techniques and benchmark new 
 donor retention strategies for a smoother journey to the clinic and beyon
 d!\n\nTime: 9:00 AM - 6:00 PM\n\nSpeakers: Ajay Vishwakarma Founder and C
 hief Executive Officer CellBioEngines\, Albert Ribickas BMT Operations Ma
 nager Moffitt Cancer Center\, Alexey Bersenev Chief Technical Officer Cel
 lBioEngines\, Amanda Medcalf Conerty Executive Director - Process\, Analy
 tical Development and Manufacturing Artiva Biotherapeutics\, Inc\, Andrew
  Gilder Senior Process Engineer Shoreline Biosciences\, Blake Aftab Chief
  Scientific Officer Adicet Bio Inc.\, Brian Garrison Vice President - Res
 earch Senti Biosciences Inc.\, Cecilia Zhang Co-founder and Chief Scienti
 fic Officer Biosyngen Group\, Cokey Nguyen President and Chief Executive 
 Officer Atara Biotherapeutics Inc.\, Dan Crowley Chief Executive Officer 
 Remedy Biologics\, Enrique Zudaire Senior Vice President - Translational 
 Sciences and Therapeutics Discovery Caribou Biosciences\, Gregg Solar Vic
 e President Process Development Shoreline Biosciences\, James Adams Chief
  Technical Officer Tr1x therapeutics\, Janet Lambert Advisor Alliance for
  Regenerative Medicine\, Kanya Rajangam President\, Head of Research and 
 Development and Chief Medical Officer Senti Biosciences Inc.\, Karen Aboo
 dy Professor City of Hope\, Kevin Nishimoto Senior Director - Preclinical
  Cell and Immunotherapy Research Adicet Bio Inc.\, Laurent Poirot Senior 
 VP Immunology Cellectis\, Leopold Bertea Chief Technology Officer Mendus\
 , Luis Borlado Executive Director Allogeneic Cell Therapy Process Develop
 ment AstraZeneca\, Monica Raimo Director\, Product and Process Developmen
 t Glycostem Therapeutics\, Olivier Negre Chief Scientific Officer Smart I
 mmune\, Raphael Ognar President\, Chief Executive Officer \, Co-Founder a
 nd Chairman of the Board NKILT Therapeutics\, Rashmi Kshirsagar Senior Vi
 ce President Be Biopharma\, Rui Tostoes Vice President - Chemistry\, Manu
 facturing\, and Controls ImmuneBridge\, Sadhak Sengupta Senior Director -
  Research and Development IN8Bio\, Shirley M Bartido Director - Global Re
 gulatory Affairs\, Cell Therapy Oncology Takeda Pharmaceutical\, So-Ching
  Brazer Executive Director\, Regulatory CMC Adicet Bio Inc.\, Stephen Che
 n Chief Technical Officer Tevogen Bio\, Tim (Tingxi) Guo Senior Scientist
  GentiBio\, Tim Gallagher Chief Business Officer PhosphoGam\, Tobias Deus
 e Co-Founder and Professor at UCSF Shionogi Inc.\, Tony Arulanandam CEO a
 nd Founder Synaptimmune Therapeutics\, Vibha Jawa Executive Director Bris
 tol Myers Squibb\, Xiaoya Sun Research\, Analytical Development and Cell 
 Therapy Investigator Takeda Pharmaceutical\n
DTEND:20250612T180000
DTSTAMP:20260512T232943Z
DTSTART:20250610T090000
LOCATION:Revere Hotel Boston Common\, 200\, Stuart Street\, Boston\, Massa
 chusetts\, 02116\,
SEQUENCE:0
SUMMARY:As the autoimmune wave breathes financial life back into the allog
 eneic space\, and a growing number of oncology pipelines entering the cli
 nic\, it i...
UID:c62033d6-b1f9-44ab-82c9-4d489cf1ec40
END:VEVENT
END:VCALENDAR